<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">The principle of CP infusion was established in 1880 when it was shown that immunity against diphtheria relied on existing antibodies in blood from animals intentionally immunized with non-lethal doses of toxins, that could be transferred to animals suffering from active infections [
 <xref rid="bb0150" ref-type="bibr">30</xref>,
 <xref rid="bb0155" ref-type="bibr">31</xref>]. Then, it was recognized that immune plasma not only neutralizes the pathogen, but also provides passive immunomodulatory properties that allow the recipient to control the excessive inflammatory cascade induced by several infectious agents or sepsis [
 <xref rid="bb0130" ref-type="bibr">26</xref>,
 <xref rid="bb0155" ref-type="bibr">31</xref>]. In the early 1950s, purification and concentration of immunoglobulins from healthy donors or recovered patients provided an option to treat serious infectious diseases as well as immune conditions including primary immunodeficiencies, allergies, and autoimmune diseases [
 <xref rid="bb0150" ref-type="bibr">30</xref>,
 <xref rid="bb0160" ref-type="bibr">32</xref>,
 <xref rid="bb0165" ref-type="bibr">33</xref>].
</p>
